Making Science Group (MAKS) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
16 Mar, 2026Executive summary
Achieved €374M in revenue for FY 2025, up 36% year-over-year, driven by international expansion and growth in service activity, with recurring EBITDA stable at €14M.
Significant international growth, with new offices in Brazil, Argentina, Germany, and the Netherlands, and a joint venture in Germany; international revenues surpassed Spain, with €216M versus €147M, driven by strong U.S. and U.K. growth.
Sale of the Cloud and Cybersecurity unit (BL2) to Lutech for up to €26M, enabling focus on core digital marketing and AI technology areas.
Workforce reduced to 826 employees post-divestment, with operational efficiencies from AI adoption.
Recognized for innovation and as a top employer, with awards from YouTube, Google, and El Mundo.
Financial highlights
Revenue increased by 36% to €374M in FY 2025 compared to FY 2024.
Gross margin rose 5% to €74.8M, with profitability maintained around 19–20%.
Core business revenue grew 38% to €363.3M, with gross margin up 7.7% to €72.2M.
International segment revenue surged 70% to €216M, with recurring EBITDA up 24% to €5.2M.
E-commerce and product investments saw a 10% revenue decline and a 54% drop in recurring EBITDA, reflecting tariff impacts.
Outlook and guidance
2026 expected to deliver profitable, sustained growth, leveraging AI-driven products and regional hubs.
2025 guidance suspended following the divestment; updated strategic plan to be communicated.
Expecting one-third of results from Spain, U.S., and other geographies each, with continued international growth and operational efficiency.
Focus remains on profitability, cash flow, debt reduction, and cost optimization.
Latest events from Making Science Group
- H1 2025 revenue up 40% to €174.6M, recurring EBITDA €7.7M, international share at 60%.MAKS
Q2 20252 Nov 2025 - Recurring EBITDA nearly doubled in H1 2024, led by strong Spain and international growth.MAKS
Q2 202411 Jul 2025 - Recurring EBITDA up 94% to €10.6M in 9M24, with robust growth and margin expansion.MAKS
Q3 202411 Jul 2025 - 2024 saw 16% revenue growth and 71% EBITDA surge, with strong international momentum.MAKS
Q4 202411 Jul 2025 - Record Q1 2025 EBITDA and 33% revenue growth driven by strong international expansion.MAKS
Q1 202511 Jul 2025 - Record Q1 2025 EBITDA and rapid international growth highlight strong execution and AI-driven strategy.MAKS
Investor Presentation11 Jul 2025